Cargando…

Prospective practice survey of management of cetuximab-related skin reactions

PURPOSE: Evidence-based guidelines on how to prevent or treat cetuximab-related skin reactions are lacking and multiple care and management strategies are used. The main purpose of the present study is to gain information about the different skincare products being used against skin reactions in met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lugtenberg, R. T., Boers-Doets, C. B., Witteveen, P. O., van Herpen, C. M. L., Wymenga, A. N. M., de Groot, J. W. B., Hoeben, A., del Grande, C., van Doorn, B., Koldenhof, J. J., Driessen, C. M. L., Gelderblom, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163687/ https://www.ncbi.nlm.nih.gov/pubmed/33150521 http://dx.doi.org/10.1007/s00520-020-05862-7

Ejemplares similares

[(89)Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
por: van Helden, E. J., et al.
Publicado: (2019)

Informal caregiver well-being during and after patients’ treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study
por: Langenberg, S. M. C. H., et al.
Publicado: (2020)

Xerosis and pruritus as major EGFRI-associated adverse events
por: Clabbers, Julia M. K., et al.
Publicado: (2015)

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008)

Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study
por: Koldenhof, J. J., et al.
Publicado: (2018)

Caregivers’ burden and fatigue during and after patients’ treatment with concomitant chemoradiotherapy for locally advanced head and neck cancer: a prospective, observational pilot study
por: Langenberg, Simone M. C. H., et al.
Publicado: (2019)

Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
por: Baas, J. M., et al.
Publicado: (2015)

Cetuximab in Refractory Skin Cancer Treatment
por: Kalapurakal, Sini J, et al.
Publicado: (2012)

Radiolabeled F(ab′)(2)-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models
por: Bellaye, P.-S., et al.
Publicado: (2018)

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer
por: van Helden, Erik J., et al.
Publicado: (2019)

Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
por: Wehler, Thomas C., et al.
Publicado: (2013)

Allergic/infusion reactions reported with cetuximab and rituximab
por: Wolf, Ray A, et al.
Publicado: (2015)

Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
por: Baas, Jara, et al.
Publicado: (2018)

Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab
por: Foley, K. A., et al.
Publicado: (2010)

Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
por: Wehler, Thomas C., et al.
Publicado: (2013)

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study
por: Rothschild, Sacha I., et al.
Publicado: (2019)

Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
por: Driessen, Chantal M. L., et al.
Publicado: (2017)

Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy
por: Gupta, Deepak, et al.
Publicado: (2011)

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study
por: Hamberg, P, et al.
Publicado: (2014)

Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters
por: Caetano-Pinto, Pedro, et al.
Publicado: (2017)

Correction of axial and rotational alignment after medial and lateral releases during balanced gap TKA: A clinical study of 54 patients
por: Heesterbeek, Petra J C, et al.
Publicado: (2010)

Local giant cell foreign body reaction after silicone injection for fecal incontinence in humans: two case reports
por: van Wunnik, B., et al.
Publicado: (2011)

Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
por: Even, Aniek J.G., et al.
Publicado: (2016)

Cetuximab in small bowel adenocarcinoma: a new friend?
por: Santini, D, et al.
Publicado: (2010)

Flexible versus standard intramedullary rod in posterior stabilized primary total knee arthroplasty: protocol for a randomized controlled trial
por: Bénard, M. R., et al.
Publicado: (2020)

Bone scintigraphy after osteochondral autograft transplantation in the knee: 13 patients followed for 4 years
por: Kock, Niels B, et al.
Publicado: (2010)

Frailty and checkpoint inhibitor toxicity in older patients with melanoma
por: Bruijnen, Cheryl P., et al.
Publicado: (2022)

(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer
por: Menke-van der Houven van Oordt, Catharina Willemien, et al.
Publicado: (2015)

Substitution of low-risk skin cancer hospital care towards primary care: A qualitative study on views of general practitioners and dermatologists
por: Noels, E. C., et al.
Publicado: (2019)

Case Report: Two Cases of Salivary Duct Carcinoma in Workers With a History of Chromate Exposure
por: Seçin, Imran, et al.
Publicado: (2021)

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
por: Merlano, Marco C, et al.
Publicado: (2018)

A systematic literature review of the human skin microbiome as biomarker for dermatological drug development
por: Niemeyer ‐ van der Kolk, T., et al.
Publicado: (2018)

Management of infusion reactions associated with cetuximab treatment: A case report
por: Ohshita, Naohiro, et al.
Publicado: (2017)

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation
por: Balin-Gauthier, D, et al.
Publicado: (2008)

Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence
por: Ham, Janneke C., et al.
Publicado: (2020)

No difference in long-term micromotion between fully cemented and hybrid fixation in revision total knee arthroplasty: a randomized controlled trial
por: Mills, Kelly, et al.
Publicado: (2022)

Feasibility of monitoring stress using skin conduction measurements during intubation of newborns
por: van der Lee, Robin, et al.
Publicado: (2015)

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting
por: Bos, Manouk K., et al.
Publicado: (2023)

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer
por: Baker, J B, et al.
Publicado: (2011)

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
por: Koldenhof, T, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_290eki5gvnvigchp6qjt378fcd